Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 421-430 of 640 total displayed.

Past content (since Jan 1999):

Letters to the Editor
More Hype Than HOPE
George D. Moutsatsos
Hypertension 2003;41: ; published online before print as doi:10.1161/01.HYP.0000060824.84130.4F [Full text]  

Letters to the Editor
Response: HOPE Not HYPE But Mechanisms Can Be Discussed
Per Svensson and Jan Östergren
Hypertension 2003;41: ; published online before print as doi:10.1161/01.HYP.0000060823.07640.6E [Full text]  

Scientific Contributions
Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension
Stefano Taddei, Agostino Virdis, Lorenzo Ghiadoni, Daniele Versari, Guido Salvetti, Armando Magagna, and Antonio Salvetti
Hypertension 2003;41:950-955; published online before print as doi:10.1161/01.HYP.0000063361.70525.3C [Abstract] [Full text]  

Scientific Contributions
AT1-Receptor Antagonism Improves Endothelial Function in Coronary Artery Disease by a Bradykinin/B2-Receptor-Dependent Mechanism
Burkhard Hornig, Christoph Kohler, Daniel Schlink, Helma Tatge, and Helmut Drexler
Hypertension published March 24, 2003, doi:10.1161/01.HYP.0000064942.77814.26 [Abstract]  

Scientific Contributions
AT1 Receptors in the RVLM Mediate Pressor Responses to Emotional Stress in Rabbits
Dmitry N. Mayorov and Geoffrey A. Head
Hypertension published March 24, 2003, doi:10.1161/01.HYP.0000064574.29317.45 [Abstract]  

Scientific Contributions
Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension
Stefano Taddei, Agostino Virdis, Lorenzo Ghiadoni, Daniele Versari, Guido Salvetti, Armando Magagna, and Antonio Salvetti
Hypertension published March 17, 2003, doi:10.1161/01.HYP.0000063361.70525.3C [Abstract]  

Letters to the Editor
More Hype Than HOPE
George D. Moutsatsos
Hypertension published March 3, 2003, doi:10.1161/01.HYP.0000060824.84130.4F [Abstract]  

Letters to the Editor
Response: HOPE Not HYPE But Mechanisms Can Be Discussed
Per Svensson and Jan Östergren
Hypertension published March 3, 2003, doi:10.1161/01.HYP.0000060823.07640.6E [Abstract]  

Letters to the Editor
Does Sildenafil Indirectly Inhibit Phosphodiesterase 3 in Vascular Smooth Muscle?
Donald H. Maurice
Hypertension 2003;41: ; published online before print as doi:10.1161/01.HYP.0000054979.81019.0A [Full text]  

Scientific Contributions
Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)
Giuseppe Mancia, Morris Brown, Alain Castaigne, Peter de Leeuw, Christopher R. Palmer, Talma Rosenthal, Gilbert Wagener, and Luis M. Ruilope
Hypertension 2003;41:431-436; published online before print as doi:10.1161/01.HYP.0000057420.27692.AD [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment